List view / Grid view

Richard JA Goodwin (Principal Scientist - Drug Safety and Metabolism at AstraZeneca)


Mass spectrometry imaging in drug discovery

11 September 2017 | By ,

Mass spectrometry imaging allows direct measurement of the molecular composition of a sample. It can be used to image the spatial distribution of exogenous drugs and endogenous metabolites simultaneously over the surface of tissue sections or small biopsy, allowing new insights into both compound efficacy and safety during drug discovery.

Send this to a friend